TCM
ALT icon

Teza Capital Management’s Altimmune ALT Stock Holding History

Teza Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,346
Closed -$75.8K – 487
2024
Q3 		$75.8K Sell
12,346
-24
-0.2% -$163 0.01% 575
2024
Q2 		$82.3K Buy
12,370
+44
+0.4% +$325 0.01% 554
2024
Q1 		$125K Buy
+12,326
New +$125K 0.02% 538
2017
Q1 		– Sell
-113
Closed -$110K – 503
2016
Q4 		$110K Buy
+113
New +$101K 0.15% 204

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Teza Capital Management's ALT Position: Q4 2024 in Review

Teza Capital Management sold out of Altimmune (ALT) in Q4 2024, closing a stake of 12,346 shares — an estimated $75.8K sold.

Teza Capital Management first reported a position in ALT in Q4 2016 and held it in 4 quarters. The position peaked at $125K in Q1 2024. 182 funds tracked by Wall St. Rank hold ALT as of Q4 2024.

  • Teza Capital Management reported no remaining Altimmune position as of Q4 2024 after selling out during the quarter.
  • Teza Capital Management sold 12,346 Altimmune shares in Q4 2024, an estimated $75.8K.
  • Teza Capital Management first reported a position in Altimmune in Q4 2016 and held it in 4 quarters.
  • Teza Capital Management's Altimmune position peaked at $125K in Q1 2024.
  • 182 funds tracked by Wall St. Rank held Altimmune as of Q4 2024.

Based on Teza Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.